Pharmacovigilance Risk Assessment Committee (PRAC) online meeting

Online meeting

April 23, 2021

Pharmacovigilance Risk Assessment Committee (PRAC)

PRAC is the European Medicines Agency's (EMA) committee responsible for assessing and monitoring the safety of human medicines. The PRAC was formally established in line with the pharmacovigilance legislation which came into effect in 2012 to help strengthen the safety monitoring of medicines across Europe. The PRAC is responsible for assessing all aspects of risk management of human medicines.

This site uses cookies to enhance your experience. When you continue to browse, you are accepting You are using an outdated browser. Please, upgrade your browser to improve your experience.